With the open letter published in EJNMMI Radiopharmacy and Chemistry by an international working group of experts, the EJNMMI journal family endorses the application of the guidelines in contributions to the journals.
Attached to the letter by the working group is a three-page summary highlighting the most relevant issues used in the notation of radiopharmaceuticals and related terms.
The full paper with all recommendations is published in “Consensus nomenclature rules for radiopharmaceutical chemistry—setting the record straight, Coenen, H.H., Gee A.D. et al., Nuclear Medicine and Biology, volume 55, v–xi (2017) (10.1016/j.nucmedbio.2017.09.004)”.
All Editors-in-Chiefs of the EJNMMI journals strongly recommend all manuscripts meet these guidelines upon submission. In addition, all reviewers will be asked to be aware of the guidelines and wherever possible to check if the guidelines are followed.
Editors-in-Chief,
Philip Elsinga
Angelika Bischof Delaloye
Arturo Chiti
Stefaan Vandenberghe
Francesco Giammarile
Ignasi Carrio
Authors’ contributions
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Footnotes
This article is co-published in the European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Research, EJNMMI Physics, EJNMMI Radiopharmacy and Chemistry, and European Journal of Hybrid Imaging, and is available at 10.1186/s41181-018-0050-3, 10.1007/s00259-018-4243-5, 10.1186/s13550-018-0469-2, 10.1186/s40658-018-0237-4 and 10.1186/s41824-018-0048-9 respectively.